This page shows the latest Fovea news and features for those working in and with pharma, biotech and healthcare.
The G-BA had earlier decided that Eylea would be compared to Lucentis in cases of DMO, which affected the fovea centralis - a pit in the back of the eye that ... The data showed no relevant differences between the treatment groups for patients in whom
and for whom there is no permanent damage to the part of the eye called the fovea.
who show signs the condition has been getting worse and for whom there is no permanent damage to the part of the eye called the fovea.
The ophthalmology division of sanofi-aventis (S-A), Fovea Pharmaceuticals, has signed a co-operation agreement with the Institut de la Vision (page is in French), one of the main eye
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
Dr Gilly, along with Professor Jose Sahel and Pierre Belichard, set up Fovea in 2005. ... Prior to his involvement with Fovea, Dr Gilly was a venture partner with Sofinnova Partners from 2000 to 2005.
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...